Dream on. Please don't pump this turd irresponsibly! At the moment, IPIX's market cap is embarrassingly at $73 million. With none of the current drugs in Phase 3 or even clinical trials being funded, realizing those hefty, ridiculous valuation ($12 billion, LOL!), if it ever be successful (big *IF*), is at least 15 years away.